Logo image of FRNT.CA

FRNT FINANCIAL INC (FRNT.CA) Stock Fundamental Analysis

TSX-V:FRNT - TSX Venture Exchange - CA30322H1001 - Common Stock - Currency: CAD

0.42  +0.01 (+1.2%)

Fundamental Rating

3

Taking everything into account, FRNT scores 3 out of 10 in our fundamental rating. FRNT was compared to 0 industry peers in the Unkown industry. The financial health of FRNT is average, but there are quite some concerns on its profitability. While showing a medium growth rate, FRNT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FRNT has reported negative net income.
FRNT had a negative operating cash flow in the past year.
In the past 5 years FRNT always reported negative net income.
In the past 5 years FRNT always reported negative operating cash flow.
FRNT.CA Yearly Net Income VS EBIT VS OCF VS FCFFRNT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -52.81%
ROE -56.9%
ROIC N/A
ROA(3y)-37.33%
ROA(5y)-33.62%
ROE(3y)-41.53%
ROE(5y)-37.84%
ROIC(3y)N/A
ROIC(5y)N/A
FRNT.CA Yearly ROA, ROE, ROICFRNT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FRNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRNT.CA Yearly Profit, Operating, Gross MarginsFRNT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K -2.5K

More info and screens

6

2. Health

2.1 Basic Checks

FRNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FRNT has more shares outstanding
FRNT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, FRNT has an improved debt to assets ratio.
FRNT.CA Yearly Shares OutstandingFRNT.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
FRNT.CA Yearly Total Debt VS Total AssetsFRNT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 25.28 indicates that FRNT is not in any danger for bankruptcy at the moment.
There is no outstanding debt for FRNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 25.28
ROIC/WACCN/A
WACC9%
FRNT.CA Yearly LT Debt VS Equity VS FCFFRNT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

A Current Ratio of 12.88 indicates that FRNT has no problem at all paying its short term obligations.
A Quick Ratio of 12.88 indicates that FRNT has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 12.88
Quick Ratio 12.88
FRNT.CA Yearly Current Assets VS Current LiabilitesFRNT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.96% over the past year.
FRNT shows a strong growth in Revenue. In the last year, the Revenue has grown by 260.47%.
Measured over the past years, FRNT shows a very strong growth in Revenue. The Revenue has been growing by 46.19% on average per year.
EPS 1Y (TTM)9.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118%
Revenue 1Y (TTM)260.47%
Revenue growth 3Y142.27%
Revenue growth 5Y46.19%
Sales Q2Q%9.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRNT.CA Yearly Revenue VS EstimatesFRNT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
FRNT.CA Yearly EPS VS EstimatesFRNT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FRNT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRNT.CA Price Earnings VS Forward Price EarningsFRNT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRNT.CA Per share dataFRNT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRNT FINANCIAL INC

TSX-V:FRNT (3/6/2025, 7:00:00 PM)

0.42

+0.01 (+1.2%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.26%
Inst Owner ChangeN/A
Ins Owners52.03%
Ins Owner ChangeN/A
Market Cap15.77M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.99
P/FCF N/A
P/OCF N/A
P/B 3.62
P/tB 3.62
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.04
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.81%
ROE -56.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-37.33%
ROA(5y)-33.62%
ROE(3y)-41.53%
ROE(5y)-37.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.88
Quick Ratio 12.88
Altman-Z 25.28
F-Score4
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-118%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)260.47%
Revenue growth 3Y142.27%
Revenue growth 5Y46.19%
Sales Q2Q%9.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.52%
OCF growth 3YN/A
OCF growth 5YN/A